Three central conventional chondrosarcoma cell lines with an IDH wildtype (CH2879) or an endogenous IDH1R132G mutation (JJ012) or IDH2R172S mutation (SW1353) were selected to elucidate the underlying growth inhibition or cell death mechanism. The gene discussed is IDH2; the disease is chondrosarcoma.